Perrigo Company plc
NYSE:PRGODrug Manufacturers - Specialty & Generic
-$0.20 today
- Market cap
- $2.35B
- Beta
- 0.52
- P/E (TTM)
- -0.8
- EPS (TTM)
- -$13.10
- Dividend yield
- 11.65%
Volume 2.57M
Average 2.96M
PRGO Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Perrigo Company plcNYSE: PRGO
Capital Expenditures · Q2 FY2026 · quarter ended Jun 2026
Capital expenditures declines year over year
Q2 FY2026 capital expenditures of $14.3M (cash outflow) fell 25.5% year over year, ahead of the -29.9% change in trailing-twelve-month capital expenditures. Sequentially, it rose 3.6% from the prior quarter. Over 3 fiscal years it compounded at -1.0% a year.
Context
- Capital expenditures amounted to 2.2% of revenue in FY2025, down 0.5 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -25.5% holds above the trailing-twelve-month pace of -29.9%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (93.4M) USD
- Year-over-year change
- +21.0%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (93.4M) | +21.0% |
| FY2024 | 2024-12-31 | (118.3M) | -16.3% |
| FY2023 | 2023-12-31 | (101.7M) | -5.5% |
| FY2022 | 2022-12-31 | (96.4M) | +36.6% |
| FY2021 | 2021-12-31 | (152.1M) | — |
Capital Expenditures vs competitors
How PRGO compares with its peers on the latest reported figures
- PRGO's LTM Jun 2026 capital expenditures of $76.8M is the 3rd largest of the 10 companies compared; the peer median is $17.46M.
- Its year-over-year change of -29.9% is the 8th highest of 10, against a peer median of -5.9%.
- Capital expenditures amounts to 1.9% of revenue for PRGO, versus a peer median of 3.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $408.39M | +1.8% | +14.0% | 3.8% | |
| LTM Sep 2026 | $108.84M | +83.8% | +45.2% | 7.2% | |
| LTM Jun 2026 | $76.8M | -29.9% | -1.0% | 1.9% | |
| LTM Sep 2026 | $75.1M | -14.9% | -0.8% | 2.2% | |
| LTM Mar 2026 | $44.61M | -35.8% | -10.0% | 5.7% | |
| LTM Sep 2026 | $17.46M | +103.6% | +169.1% | 2.6% | |
| LTM Jun 2025 | $17.09M | -6.9% | -27.1% | 2.8% | |
HTFLHeartflow, Inc. Common Stock | LTM Sep 2026 | $7.11M | +105.7% | — | 3.0% |
| LTM Jun 2026 | $1.12M | -5.9% | +48.1% | 0.1% | |
| LTM Sep 2026 | $202K | -65.9% | -17.3% | 35.4% | |
| Peer median (excluding PRGO) | $17.46M | -5.9% | +6.6% | 3.0% | |
Competitors are the stored peer set for PRGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (68.9M) | (130.9M) | (12.7M) | (171.8M) | (1.4B) |
| Depreciation & Amortization | 312.2M | 338.6M | 359.5M | 325.9M | 337.5M |
| Deferred Income Tax | 9.4M | (50.5M) | (106.6M) | 9.8M | (50.8M) |
| Stock-Based Compensation | 60.1M | 0 | 68.8M | 64.4M | 0 |
| Change in Working Capital | (295.4M) | 20M | (58.5M) | (74.7M) | (101.1M) |
| Accounts Receivables | (159.7M) | 100K | (57.1M) | (11.1M) | 30.7M |
| Inventory | (2.4M) | (76.7M) | 19.4M | 13.7M | (61.1M) |
| Accounts Payables | (7.9M) | 100.3M | (65.9M) | 54.2M | (28.7M) |
| Other Working Capital | (125.4M) | (3.7M) | 45.1M | (131.5M) | (42M) |
| Other Non-Cash Items | 138.9M | 130.1M | 155M | 209.3M | 1.46B |
| Operating Cash Flow | 156.3M | 307.3M | 405.5M | 362.9M | 238.5M |
| Capital Expenditures | (152.1M) | (96.4M) | (101.7M) | (118.3M) | (93.4M) |
| Acquisitions (Net) | 1.49B | (1.95B) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (64M) | 90.5M | 24.2M | 197.1M | 18M |
| Investing Cash Flow | 1.28B | (1.96B) | (77.5M) | 78.8M | (75.4M) |
| Debt Repayment | (30.6M) | 583.6M | (30.2M) | (437.8M) | (34.8M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (129.6M) | (142.4M) | (149.7M) | (152.5M) | (159.3M) |
| Other Financing Activities | (18.5M) | (19.6M) | (7.3M) | (20.7M) | (26.4M) |
| Financing Cash Flow | (178.7M) | 421.6M | (187.2M) | (611M) | (220.5M) |
| Effect of Forex Changes | (15.6M) | (34.5M) | 9.8M | (23.2M) | 30.2M |
| Net Change in Cash | 1.23B | (1.26B) | 150.6M | (192.5M) | (27.2M) |
| Free Cash Flow | 4.2M | 210.9M | 303.8M | 244.6M | 145.1M |
Perrigo Company plc
NYSE:PRGO
Intrinsic Alpha fair value
Locked
Current Price
$16.94
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.